Cancer News

Recent updates from the National Comprehensive Cancer Network (NCCN) emphasize a significant shift in the approach to prostate cancer screening. The new patient guidelines aim to clarify the benefits...

Recent research from the Mayo Clinic has unveiled critical mechanisms behind the resistance of certain breast cancers to innovative treatments known as antibody-drug conjugates (ADCs). This discovery...

Researchers at the Mayo Clinic have recently unveiled crucial findings regarding why some breast cancers fail to respond effectively to a promising class of treatments known as antibody-drug...

Recent research from the Mayo Clinic has unveiled critical insights into why certain breast cancers do not respond to a promising class of therapies known as antibody-drug conjugates (ADCs). This...

Recent research from the Mayo Clinic has uncovered critical insights into why certain breast cancers exhibit resistance to a promising class of therapies known as antibody-drug conjugates (ADCs)....

As prostate cancer remains one of the most prevalent forms of cancer among men, new discussions around radiation therapy treatments and their outcomes are emerging. Experts in the field are now...

Recent developments in radiation therapy for prostate cancer have sparked significant interest among healthcare professionals and patients alike. A team of experts has made themselves available to...

Recent discussions among prostate cancer experts highlight significant advancements in radiation therapy treatments and their outcomes, promising new hope for patients facing this challenging...

In a significant recognition of his contributions to cancer research, Dr. Dennis Slamon has been elected to the Association of American Physicians (AAP). His groundbreaking work in identifying the...

Recent advancements in cancer risk prediction are making waves in the field of oncology, particularly with the introduction of a new tool designed to more accurately assess the likelihood of...

Recent funding awards announced by the National Comprehensive Cancer Network® (NCCN®) are set to drive innovative quality improvement initiatives for patients with Chronic Myeloid Leukemia (CML). The...

Recent research has unveiled critical mechanisms behind the formation of precancerous lesions in the pancreas, a development that could significantly impact the early detection and prevention of one...

Recent advancements in cancer treatment are offering new hope for patients battling advanced melanoma, a particularly aggressive form of skin cancer. Researchers at UT Southwestern Medical Center are...

Advancements in cancer treatment continue to evolve, offering new possibilities for patients battling advanced melanoma, a particularly aggressive form of skin cancer. Recent research highlights the...

In the realm of pediatric oncology, few endeavors are as critical as the pursuit of innovative treatments tailored specifically for children battling cancer. Dr. Jessica Sheth Bhutada, an attending...

The journey of surviving cancer is often accompanied by a daunting financial aftermath. While advancements in oncology have led to increased survival rates, the costs associated with ongoing care can...

Recent research from UCLA Health has unveiled a promising approach to predicting patient responses to combination immunotherapy in melanoma, a particularly aggressive form of skin cancer. By...

Recent updates from Inhibrx Biosciences regarding their investigational drug, ozekibart (INBRX-109), have sparked interest in the oncology community, particularly for patients suffering from...

In a significant move aimed at improving cancer education and outreach, the Association of American Cancer Institutes (AACI) has announced a partnership with Medlive, designating the latter as its...

The National Comprehensive Cancer Network (NCCN) recently celebrated significant achievements in cancer care at its 2026 Annual Conference in Orlando, Florida. The event highlighted the dedication of...